CIK 0000072444 · Accelerated filer<br>Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 591212264
- Phone
- (650) 550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- 4 Insider Changes in Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- SC 13G Stake Amended Statement of Ownership
- DEF 14A Proxy Proxy Statement
- 8-K/A Event Results of operations
- 8-K/A Event Results of operations
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Results of operations · Executive or director change · Other events
- 4 Insider Changes in Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Acquisition or sale completed
- 8-K Event Material agreement · Executive or director change
- 10-Q Report Quarterly Report
Page 64 of 89 · 1,773 filings